Filters close
Released: 1-May-2023 10:25 AM EDT
In-person Poster Hall and Traditional Meeting Length Returning for ACR Convergence 2023
American College of Rheumatology (ACR)

ACR Convergence 2023, the annual meeting of the American College of Rheumatology (ACR), will be held Nov. 10 – 15 at the San Diego Convention Center. This year’s meeting includes the return of an in-person poster hall, five in-person networking lounges, CME for select plenary sessions, and more.

Released: 14-Mar-2023 1:35 PM EDT
New Guideline Introduces Recommendations for Optimal Timing of Elective Hip or Knee Arthroplasty
American College of Rheumatology (ACR)

The ACR and the American Association of Hip and Knee Surgeons (AAHKS) released a summary of its new guideline titled “the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Osteonecrosis Who Have Failed Nonoperative Therapy.”

Released: 21-Dec-2022 10:00 AM EST
2022 Specialty Match Day Results Show Strong Appeal of Adult Rheumatology and Need to Increase Interest in Pediatric
American College of Rheumatology (ACR)

The ACR welcomes an impressive pool of applicants to the field of rheumatology. 75% of candidates interested in adult rheumatology and 96% of applicants interested in pediatric rheumatology were matched to fellowship programs for the 2023 National Residents Matching Program appointment year.

Released: 15-Dec-2022 3:45 PM EST
American College of Rheumatology: Proposed Rule Will Bring Great Transparency to Medicare Advantage Prior Authorization
American College of Rheumatology (ACR)

The American College of Rheumatology said the Centers for Medicare and Medicaid Services’ Advancing Interoperability and Improving Prior Authorization Proposed Rule will bring greater transparency, reduce administrative burden, & make turnaround on prior authorization more predictable for payers.

Released: 8-Nov-2022 12:55 PM EST
Higher-Dose Pneumococcal Vaccines Improve Immune Response in ANCA-associated Vasculitis Patients Receiving Rituximab
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

Released: 8-Nov-2022 12:50 PM EST
Study Finds Most Fetal Congenital Heart Block Screening Fails to Meet Guidelines
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that most echocardiography screening for fetal congenital heart block in anti-Ro- and anti-La-positive pregnancies did not follow recommended guidelines in one academic medical center.

Released: 8-Nov-2022 12:45 PM EST
Study Finds Spine Disease Is More Common in Chronic Recurrent Multifocal Osteomyelitis than Previously Thought
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as many as 10-35% of patients and is asymptomatic in one-third.

Released: 8-Nov-2022 12:45 PM EST
Study Finds Holding Methotrexate for One Week after Flu Vaccine May Be as Effective as a Two-Week Hold
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, showed that discontinuing methotrexate for 1 week after seasonal influenza vaccination provided the same seroprotection as a 2 week discontinuation period in patients with RA.

Released: 8-Nov-2022 12:45 PM EST
Study Finds Combination Therapy Does Little to Slow Spine Damage in Radiographic Axial Spondyloarthritis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that combining a nonsteroidal anti-inflammatory drug and TNF inhibitor did not significantly slow radiographic spinal progression in radiographic axial spondyloarthritis patients.

Released: 8-Nov-2022 12:40 PM EST
Study Finds No Increased Cancer Risk in Rheumatology Patients with History of Malignancy Taking DMARDS and TNF Inhibitors
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the organization's annual meeting, found no significant difference in cancer risk in patients with rheumatic disease & a history of malignancy taking biologic or targeted synthetic DMARDs compared to those treated with TNF inhibitors.

Released: 8-Nov-2022 12:30 PM EST
Study Finds Opioids Double Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).

Released: 8-Nov-2022 12:20 PM EST
Study Links Lower Hydroxychloroquine Dose to More Hospitalizations for Systemic Lupus Erythematosus Flares
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual scientific meeting, found that the recommended weight-based or non-weight-based dose of hydroxychloroquine led to more hospitalizations for flares among patients with systemic lupus erythematosus

Released: 8-Nov-2022 12:15 PM EST
Primary Care Provider Training Program Improves RA Care on Navajo Nation
American College of Rheumatology (ACR)

Research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, described a novel program that offers rheumatoid arthritis (RA) training to primary care providers in the Navajo Nation, the largest American Indian reservation in the United States.

Released: 8-Nov-2022 12:05 PM EST
Study Finds Early TNF Inhibitor Treatment Is Associated with Higher Heart Disease Risk in Ankylosing Spondylitis Patients — with Caveats
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that early initiation of tumor necrosis factor (TNF) inhibitors was associated with higher risk of heart disease in patients diagnosed with ankylosing spondylitis.

Released: 8-Nov-2022 11:55 AM EST
Study Finds More Polyarticular JIA Patients Achieve Clinical Remission with Combined Conventional and Biologic DMARDs
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, demonstrated that polyarticular JIA patients were more likely to achieve clinical remission with a combination of conventional and biologic DMARDs compared with other treatment plans.

Released: 8-Nov-2022 11:55 AM EST
Study Finds NSAID Use and Age May Delay Conception in Spondyloarthritis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and older age were associated with longer time to conception in spondyloarthritis patients.

Released: 8-Nov-2022 11:55 AM EST
New Analysis Finds Belimumab Improves Cutaneous Lupus Erythematosus in Patients with or without SLE
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not patients also had systemic lupus erythematosus (SLE or lupus).

Released: 8-Nov-2022 11:50 AM EST
Study Finds Lower Risk of Severe Infection and Hospitalization with Belimumab Compared to Oral Immunosuppressants
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the biologic B-cell inhibitor belimumab was associated with a lower risk of severe infections and hospitalizations compared to nonbiologic immunosuppressants.

Released: 8-Nov-2022 11:35 AM EST
Artificial Intelligence Shows Potential for Accurate Assessment of Nailfold Changes in Systemic Sclerosis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that the Vision Transformer, an open-source computer vision algorithm, could detect changes in nailfold capillaroscopy images from systemic sclerosis patients.

Released: 8-Nov-2022 11:30 AM EST
Researchers Develop a Risk Score to Help Detect ILD in Systemic Sclerosis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, described a first-of-its-kind validated tool to screen for systemic sclerosis-associated interstitial lung disease.

Released: 8-Nov-2022 11:20 AM EST
Holding Mycophenolate Mofetil for 10 Days or More May Improve COVID-19 Vaccine Response
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated that withholding mycophenolate mofetil for 10 days significantly increased antibody response after 2 doses of COVID-19 vaccine, without a significant increase in flares.

Released: 8-Nov-2022 11:10 AM EST
Preterm Birth More Common in Unvaccinated Pregnant Patients with Rheumatic Disease and COVID-19
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found a greater number of preterm births in unvaccinated versus fully vaccinated pregnant patients with rheumatic disease and COVID-19.

Released: 8-Nov-2022 11:05 AM EST
Study Finds Gastrointestinal Symptoms in Systemic Scleroderma Unrelated to Disease-Specific Medications
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and worsening gastrointestinal symptoms in early systemic scleroderma.

Released: 8-Nov-2022 11:05 AM EST
Study Finds AAV Characteristics and Treatments Vary Across Lifespan
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated an association between age of diagnosis and clinical characteristics and treatments in Anti-neutrophil cytoplasmic antibody-associated vasculitis patients.

Released: 8-Nov-2022 10:05 AM EST
Study Finds Half of Patients with Low-Grade Proteinuria Develop Treatable Lupus Nephritis within Two Years
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that 50% of people with low-grade proteinuria, which is protein in your urine, progress to clinical proteinuria within two years and show treatable lupus nephritis on biopsies.

Released: 7-Nov-2022 12:25 PM EST
New Guideline Introduces Recommendations for Integrative Approach to RA Treatment
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) released a summary of its new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis. This is the first ACR guideline about an Integrative Approach to RA.

Released: 2-Nov-2022 11:30 AM EDT
American College of Rheumatology Educating Dermatologists and Nephrologists on Lupus Clinical Trials Racial Disparities
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.

Released: 11-Oct-2022 10:10 AM EDT
American College of Rheumatology Announces 2022 Award Recipients
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP) proudly recognizes the recipients of its 2022 Master of the ACR and ARP designations, ACR Awards of Distinction, and ARP Awards of Merit and Appreciation.

Released: 22-Sep-2022 10:50 AM EDT
Press Registration Now Open for ACR Convergence 2022
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is providing complimentary registration to journalists wishing to write about studies presented at ACR Convergence 2022, the ACR’s annual meeting taking place Nov. 10 – 14.

Released: 20-Sep-2022 10:35 AM EDT
Rheumatology Leaders & Patient Advocates Convene on Capitol Hill to Advocate for Legislation to Improve Access to Care
American College of Rheumatology (ACR)

Physicians & health professionals from the American College of Rheumatology (ACR) along with rheumatology patients gathered on Capitol Hill this week for the annual Advocates for Arthritis event to urge lawmakers to take action on a range of policy issues affecting patient access to care.

Released: 14-Sep-2022 9:15 AM EDT
Updated Guideline Introduces Recommendations for Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) released a summary of its updated guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. New osteoporosis medications and new literature have become available since the last ACR treatment guideline was published in 2017.

Released: 8-Sep-2022 12:20 PM EDT
American College of Rheumatology Comments on 2023 Medicare Physician Fee Schedule & Quality Payment Program Rules
American College of Rheumatology (ACR)

In comments submitted to the Centers for Medicare and Medicaid Services (CMS) in response to the CY 2023 Medicare Physician Fee Schedule and Quality Payment Program proposed rule, the ACR applauded proposals that would provide more flexibility and improve care coordination.

Released: 15-Aug-2022 10:10 AM EDT
American College of Rheumatology Applauds Key Drug Pricing Reforms in Inflation Reduction Act
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) today applauded the passage of key drug pricing reforms in the Inflation Reduction Act that will improve rheumatology patients’ access to needed drug therapies and treatments.

Released: 3-Aug-2022 10:25 AM EDT
New Guideline Introduces Recommendations for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) released a summary of its new treatment guideline for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases (RMDs). The effectiveness and safety of vaccines may differ in rheumatology patients as compared to the general population.

Released: 28-Jul-2022 3:40 PM EDT
ACR Statement on Access to Reproductive Healthcare
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is deeply concerned about the U.S. Supreme Court’s Dobbs v. Jackson ruling because it negatively impacts the practice of rheumatology.

Released: 25-May-2022 11:45 AM EDT
ACR Urges the FTC to Examine the Impact of Pharmacy Benefit Managers on Prescription Drug Costs
American College of Rheumatology (ACR)

In comments submitted to the Federal Trade Commission (FTC), the American College of Rheumatology (ACR) urged the agency to address Pharmacy Benefit Manager (PBM) business practices that drive up costs and reduce access for the 54 million Americans living with rheumatic disease.

Released: 24-Mar-2022 4:30 PM EDT
American College of Rheumatology Honored with Sixth Consecutive Top Atlanta Workplace Designation
American College of Rheumatology (ACR)

The Atlanta Journal-Constitution (AJC) recognized the American College of Rheumatology (ACR) as one of Atlanta's top workplaces for the sixth year in a row. Only 87 small businesses and 175 organizations total received the recognition, and the ACR ranked 28th in the small business category.

Released: 8-Mar-2022 2:15 PM EST
New Kawasaki Disease Guideline Released by American College of Rheumatology and Vasculitis Foundation
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released a new guideline for the management of Kawasaki disease that addresses diagnostic issues relating to the disease, the treatment of high-risk patients, & the management of convalescent patients.

Released: 3-Mar-2022 9:30 AM EST
The American College of Rheumatology Releases Two Updated Guidelines for Treatment of Juvenile Idiopathic Arthritis
American College of Rheumatology (ACR)

The ACR released two updated guideline papers for the treatment and management of Juvenile Idiopathic Arthritis (JIA). These two guidelines are companions to previously updated JIA guidelines released in 2019 covering the treatment of polyarthritis, sacroiliitis, uveitis and enthesitis.

Released: 28-Feb-2022 1:15 PM EST
Updated Guideline Introduces New Recommendations for Use of Medications Around Total Hip and Knee Replacement
American College of Rheumatology (ACR)

The ACR and the AAHKS released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

Released: 23-Feb-2022 12:15 PM EST
New American College of Rheumatology Initiatives Aim to Close the Gap on Racial Disparities in Lupus Clinical Trials
American College of Rheumatology (ACR)

The ACR is launching new initiatives to reduce racial disparities in lupus clinical trials: Training to Increase Minority Enrollment in Lupus Clinical Trials with CommunitY Engagement (TIMELY) and new Continuing Medical Education (CME) for dermatologists and nephrologists.

Released: 11-Jan-2022 12:55 PM EST
Complimentary Press Registration Available for the 2022 Winter Rheumatology Symposium
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented at the Winter Rheumatology Symposium in Snowmass Village, CO on January 22 -28, 2022.

Released: 20-Dec-2021 12:00 PM EST
2021 Specialty Match Day Results Show Need to Increase Interest in Pediatric Rheumatology Fellowships
American College of Rheumatology (ACR)

The American College of Rheumatology is pleased to welcome an impressive pool of applicants to the field of rheumatology as part of the annual National Residents Matching Program (NRMP). While adult programs filled about 100 percent of their available slots, the pediatric programs only filled 69 percent, signaling a need to increase interest in pediatric rheumatology.

Released: 2-Nov-2021 4:30 PM EDT
Study Observes Worse COVID-19 Vaccine Response in Patients Taking Glucocorticoids or B-Cell Therapies
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.

Released: 2-Nov-2021 4:20 PM EDT
Study Finds TNF Inhibitor More Effective with Regular Serum Assessment to Adjust Dose
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that proactive therapeutic drug monitoring, a newer treatment strategy where a patient’s drug serum levels are regularly assessed to adjust the dose and intervals, controlled disease more effectively than standard therapy with infliximab, a tumor necrosis factor (TNF) inhibitor.

Released: 2-Nov-2021 4:15 PM EDT
New Artificial Neural Network Detects Radiographic Sacroiliitis with Accuracy
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that an innovative new artificial neural network can detect radiographic sacroiliitis in patients with suspected axial spondyloarthritis, a progressive disease that is more common in young adults.

Released: 2-Nov-2021 4:05 PM EDT
Study Finds Statins Lower CVD and Mortality in People with RA, Only Modestly Increase Diabetes Risk
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that statins are associated with reduced rates of cardiovascular disease (CVD) and mortality in people with rheumatoid arthritis, but only modestly increase risk of type-2 diabetes, suggesting that statins’ benefits outweigh the risks in these patients.

Released: 2-Nov-2021 3:45 PM EDT
Study Finds Treat-to-Target ULT Strategy Manages Gout Effectively and Safely with No Cardiovascular Toxicity
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. Importantly, both urate-lowering therapies were very effective with 90% of patients reaching target urate levels. Additionally, both appeared safe, with no evidence of increased cardiovascular toxicity.



close
0.22199